Dr. Waël Hanna is a thoracic surgeon, researcher, entrepreneur and innovator whose more than a decade of lung cancer research has culminated in NodeAI, a McMaster spinout and Hamilton-based medical AI company he co-founded in 2023.

He founded NodeAI because he believes every patient, everywhere, deserves the level of care he offers his own patients in Hamilton. As Co-founder and Chief Medical Officer, Dr. Hanna is pioneering the integration of Artificial Intelligence in lung cancer staging to transform patient outcomes and diagnostic precision.

Dr. Hanna’s dual expertise in advanced thoracic surgery and health tech leadership allows him to work at the forefront of medical innovation. Through NodeAI, he is bridging the gap between traditional surgical excellence and next-generation augmented medical technology.

Emile Maamary is the Co-Founder and Chief Marketing Officer of Steadiwear, a company dedicated to restoring independence to those living with Parkinson’s disease and essential tremor. Inspired by the struggles of his own family members with tremors, Emile made it his mission to create accessible, non-invasive solutions.

The company has successfully transformed a deeply personal insight into a globally relevant medical technology that addresses a significant unmet need for individuals living with essential tremor and Parkinson’s disease.

Rather than relying on invasive procedures or pharmaceutical interventions, Steadiwear has pioneered a clinically validated, battery-free wearable medical device that restores independence and improves quality of life through an elegant engineering solution inspired by vibration control systems used in earthquake-resistant structures.

Dr. Razieh Salahandish is the Founder and CEO of WearDoXX, which has developed a state-of-the-art biosensor that turns sweat into real-time health data.

Using advanced AI algorithms, the device can detect small physiological changes linked to early health issues or disease progression, often before a patient notices any symptoms. By delivering ongoing health data outside of clinic appointments, the biosensor could help primary care physicians and medical teams manage patient health more proactively.

Dr. Salahandish is also an Assistant Professor of York’s Lassonde School of Engineering where she also serves as the Director of the Laboratory of Advanced Biotechnologies for Health Assessment (LAB-HA) and oversees 19 funded research projects and 40 students.